Orexo

Sustainability Report and Carbon Intensity Rankings

Is Orexo doing their part?

Their DitchCarbon score is 48

Orexo has a DitchCarbon Score of 48 out of 100, indicating a moderate level of sustainability in their operations. This score reflects the company’s carbon intensity, suggesting there is significant room for improvement in reducing emissions. A higher score would demonstrate a stronger commitment to lowering carbon intensity and enhancing environmental sustainability.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

Orexo is part of the industrial manufacturing sector, which has a very low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which Orexo operates in.

Location emissions intensity

Very low

Low

Medium

High

Very high

Orexo is situated in Sweden, a country with a very low carbon intensity rating, indicating a cleaner energy grid. This favorable environmental context supports Orexo’s sustainability efforts by reducing the carbon footprint associated with their operations.

Unlock 30+ emissions intelligence data points

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

Unlock 30+ emissions data points on Orexo

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

6.71%

...this company is doing 6.71% better in emissions than the industry average.

Founded in 1995 and headquartered in Uppsala, Sweden, Orexo operates within the industrial manufacturing sector, specializing in the development of pharmaceuticals with a focus on drug delivery technologies. The company’s primary market is the United States, where it commercializes Zubsolv® for the treatment of opioid dependence. Orexo’s portfolio extends to other therapeutic areas and products, with a strong commitment to innovation and addressing unmet medical needs.

Compare Orexo with other companies in the same industry –>

emission intelligence's platform recommendations for Orexo

Orexo should undertake a thorough inventory of all Scope 1 emissions sources to identify and mitigate direct greenhouse gas emissions, potentially reducing their emissions by 15%.

Bad news, Orexo hasn't committed to SBTi climate goals yet

Orexo has not established specific commitments with the Science Based Targets initiative (SBTi) yet. This means the company has not publicly defined or committed to precise targets for reducing greenhouse gas emissions in line with climate science.

Not participating

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Other company reports in this industry

Looking for a specific company?

Search our company directory or contact us for custom data requests.

Orexo

Sustainability Report and Carbon Intensity Rankings

Is Orexo doing their part?

Their DitchCarbon score is 48

Industry emissions intensity

Very low

Low

Medium

High

Very high

Location emissions intensity

Very low

Low

Medium

High

Very high

Unlock 30+ emissions intelligence data points

Unlock 30+ emissions data points on Orexo

...this company is doing 6.71% better in emissions than the industry average.

emission intelligence's platform recommendations for Orexo

Bad news, Orexo hasn't committed to SBTi climate goals yet

Claim this profile

Our methodology

Other company reports in this industry

Looking for a specific company?

Quicklinks

Resources

Get in touch